Allergan to file ubrogepant for migraine early next year

18th October 2018 Uncategorised 0

Allergan is gearing up to file its oral CGRP receptor ubrogepant in the US for the treatment of migraine, following the success and completion of two safety studies.

More: Allergan to file ubrogepant for migraine early next year
Source: News